Australia's Cogstate hits one-month high on upbeat half-yearly earnings
** Shares of Australia's Cogstate CGS.AX rise as much as 7.3% to A$2.36, their highest level since December 22 ** Stock hits biggest intraday pct gain in one month ** Biotech co posts HY revenue of $26.9 million, up from $23.9 million a year ago ** Stock rose more than two-folds in 2025, down 2.7% YTD (Reporting by Aamir Sheik Khalid in Bengaluru) ((Aamir.SheikKhalid@thomsonreuters.com))
Recent news on Cogstate
See all newsAustralia's Cogstate gains most in nearly 2 months on revenue boost from contracts
Brief: Cogstate Posts 3Q26 Sales Contracts Executed Total $25.4 Million
Australia's Cogstate hits one-month high on upbeat half-yearly earnings
Brief: Cogstate Ltd Forecasts 1H26 Revenue At $25-$26 Million
Australia's Cogstate tumbles most in nearly 7 years on weak outlook